Genmab Market Cap

Genmab has a market cap or net worth of 125.17 billion as of December 5, 2025. Its market cap has increased by 36.29% in one year.

Market Cap

125.17B

Enterprise Value

104.36B

Revenue

24.48B

Ranking

n/a

PE Ratio

12.72

Stock Price

2,032.00

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 3.68B to 125.17B, an increase of 3,297.47%. That is a compound annual growth rate of 15.05%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	125.17B	32.02%
Dec 30, 2024	94.81B	-32.65%
Dec 29, 2023	140.77B	-26.77%
Dec 30, 2022	192.23B	11.72%
Dec 30, 2021	172.06B	6.80%
Dec 30, 2020	161.11B	67.11%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Novo Nordisk	1,349.93B
Coloplast	130.13B
ALK-Abelló	51.14B
Demant	46.18B
H. Lundbeck	41.69B
Zealand Pharma	34.69B
Ambu A/S	23.03B
Embla Medical	15.47B

Market Cap Rankings